M1-20 is a CDK1 inhibitor. M1-20 promotes CDK1 ubiquitination by CUL4-DDB1-DCAF1 complexes and degradation through the proteasome pathway. M1-20 abolishes the formation of CDK1/CCNB1 complexes. M1-20 has significant anticancer activity of spontaneous breast cancer in FVB/N MMTV-PyVT mice model[1].
Molecular Weight:
3571.17
Formula:
C153H269N53O43S
Target:
CDK
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
